Managing Cutaneous Manifestations of Hyperandrogenic Disorders

@article{Wiegratz2002ManagingCM,
  title={Managing Cutaneous Manifestations of Hyperandrogenic Disorders},
  author={Inka Wiegratz and Herbert Kuhl},
  journal={Treatments in Endocrinology},
  year={2002},
  volume={1},
  pages={373-386}
}
Cutaneous manifestations of hyperandrogenic disorders (acne, seborrhea, hirsutism and androgenetic alopecia) can be caused by elevated levels of free testosterone or androgen precursors. In women with normal serum levels of testosterone or androgen precursors, enhanced local conversion to testosterone, or to the more potent androgen dihydrotestosterone, may lead to increased androgen activity in the pilosebaceous unit. Large individual variations in the response to normal or elevated androgens… Expand
Androgenetic alopecia and current methods of treatment.
TLDR
By far the most promising approaches to the treatment of baldness in men are drug therapies, such as topical minoxidil and finasteride administered systemically. Expand
Hirsutism: Diagnosis and management.
TLDR
An updated review of hirsutism is provided, focusing on the etiologies, clinical features, approach to diagnostic evaluation, and treatment options, from 1981 to the present. Expand
Skin microbiota in women of reproductive age in norm and androgen-dependent dermatoses
TLDR
The investigation of the skin microbial component in androgen-dependent dermatoses, such as acne and seborrheic dermatitis, will contribute to understanding the pathogenic mechanisms of these diseases and to developing effective methods of therapy. Expand
Polymorphic CAG repeat numbers in the androgen receptor gene of female pattern hair loss patients
TLDR
The efficacy of this medicine in each FPHL patient cannot be predicted by the CAG repeat numbers in the AR gene, and no statistical significance was detected among the four groups classified on the basis of the efficacy of finasteride. Expand
Metformin Treatment is Effective in Obese Teenage Girls With PCOS
TLDR
Metformin has favorable effects on ovulation in moderately obese adolescents with PCOS, and may well be a more appropriate treatment than estrogen and progestin in these patients, not only promoting ovulation but relieving symptoms of hyperandrogenism. Expand
Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - Part II*
TLDR
In this second part of the study, chronic telogen effluvium and diffuse alopecia areata are discussed in detail, including clinical, dermoscopic and histological aspects. Expand
[Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].
  • E. Knop, N. Knop, +4 authors F. Schirra
  • Medicine
  • Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
  • 2009
TLDR
Careful investigation of the eyelids and lid margins with eversion, if necessary, should therefore be performed in every case of a wetting defect, notably before fitting contact lenses. Expand
Hormonal therapies and meningioma: is there a link?
TLDR
The results do not support a role for exogenous hormone use by females in meningioma development and the risk in males was only observed with high-dose, short-term (<1 year) therapy. Expand
Ovulationshemmer bei Risikogruppen
TLDR
The hormonal methods and non-hormonal alternatives available for contraception are elucidated according to existing lesions and risk factors and the advantages and disadvantages are discussed. Expand
Desafio clínico e histológico no diagnóstico diferencial de alopecia difusa: alopecia androgenética, eflúvio telógeno e alopecia areata - parte I
TLDR
In this second part of the study, chronic telogen effluvium and diffuse alo- pecia areata are discussed in detail, including clinical, dermoscopic and histological aspects. Expand
...
1
2
...

References

SHOWING 1-10 OF 68 REFERENCES
Inhibition of skin 5α-reductase by oral contraceptive progestins in vitro
TLDR
Data demonstrate that the progestins norgestimate and dienogest in particular combined 5α-reductase inhibition with minimal androgenic potential and might help in the treatment of clinical hyperandrogeny in women. Expand
Androgen conjugates: physiology and clinical significance.
TLDR
Serum levels of testosterone, androstenedione, and dehydroepiandrosterone sulfate (DHEAS) have been used as markers of overproduction of androgens or their precursors and are often elevated in hirsute women, but it has been more difficult to find markers of skin sensitivity to androgens. Expand
Androgenetic alopecia: an autosomal dominant disorder.
  • W. Bergfeld
  • Medicine
  • The American journal of medicine
  • 1995
TLDR
The acute onset of alopecia in those with inflammatory diseases of the scalp suggests a variety of etiologies, including the impact of inflammatory cells, release of cytokines, presence of growth factors, and increased interaction of stromal cells. Expand
Hirsutism in women. Effective therapy that is safe for long-term use.
TLDR
Combination therapies, specifically oral contraceptives along with antiandrogen agents, are the most effective and addition of low-dose GnRH agonist therapy prolongs remission of hirsutism and most methods produce improvement within 6 months, with continued improvement at 12 months. Expand
Role of hormones in pilosebaceous unit development.
TLDR
The biological and endocrinological basis of PSU development and the hormonal treatment of the PSU disorders hirsutism, acne vulgaris, and pattern alopecia are reviewed. Expand
Increased 5α-reductase activity in idiopathic hirsutism*†
TLDR
In vitro 5 α -RA in IH appears to be independent of serum androgen levels and is, therefore, an inherent abnormality, because hirsutism in these patients may be explained on the basis of increased skin 5α -RA. Expand
Effect of low-dose oral contraceptives on androgenic markers and acne.
TLDR
Low-dose OC (EE, 20 micrograms) are effective in reducing circulating androgens and acne lesions without causing weight gain and, although LNG and NETA affected secondary markers differently, both OC formulations produced an equivalent decrease in bioavailable. Expand
Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17β-estradiol
TLDR
Considering the good clinical results and the avoidance of any hepatic effect, this association should be taken into account in the treatment of hirsutism, especially in case of oral estrogen intolerance. Expand
The effect of metformin on hirsutism in polycystic ovary syndrome.
TLDR
It is demonstrated that metformin treatment in a group of women with PCOS results in a clinically and statistically significant improvement in hair growth compared with placebo. Expand
Antiandrogens in the treatment of acne and hirsutism.
TLDR
Clinical results indicate that those agents are most effective which not only competitively inhibit androgen binding at the receptor level but also suppress androgen secretion and/or production. Expand
...
1
2
3
4
5
...